Industrialization for CGT Scalability: Highlights From the Advanced Therapies USA Conference
PushButton AI Team ·
Industrialization for CGT Scalability: Highlights From the Advanced Therapies USA Conference
The biggest AI lesson from biotech isn't about biotech.
At a recent advanced therapies conference, the clearest takeaway wasn't "add more AI." It was this: reduce operational complexity first, then l
The biggest AI lesson from biotech isn't about biotech.
At a recent advanced therapies conference, the clearest takeaway wasn't "add more AI." It was this: reduce operational complexity first, then layer in AI to monitor what already works.
That's the opposite of how most vendors sell it to you.
You've probably felt this. You bought the tool, it sat unused, and now it's a $200/month reminder that something didn't click. That's not a you problem. That's a sequencing problem. AI dropped into a messy process just makes a faster mess.
Here's what the smartest operators figured out: pick one repetitive quality checkpoint in your business — something your team does manually every day — and ask if AI can flag exceptions instead of humans reviewing everything.
That's it. One checkpoint. Not a transformation. Not a platform migration.
Start there. You don't need to rebuild anything. You need to find the one spot where your team is spending time checking things that rarely change — and let AI handle the routine so your people handle the exceptions.
That's a 30-day win with zero disruption.
What's one repetitive task in your business that your team checks daily but rarely finds anything wrong with?
Key themes included reducing operational complexity, implementing real-time quality systems with AI integration ... artificial intelligence (AI) to ...
